semaglutide patent protection New Delhi, March 20, 2026 – The primary protecting semaglutide, the powerhouse ingredient in Novo Nordisk's globally renowned Ozempic and Wegovy, officially expired in India on Friday, March 20, 2026. This Semaglutide patent expiry in India

In some cases, more significant side effects could occur, so its essential to monitor ones health and report any concerns to a healthcare provider

A proof-of-concept analysis from the ongoing RESTORE clinical trial, conducted by researchers at the University of Colorado Anschutz Medical Campus, examined the impact of injectable semaglutide among participants aged 12 to 35 years with PCOS and obesity

The FLOW trial

Dehydration and electrolyte imbalances can also contribute, making hydration and balanced nutrition essential during treatment

Previous randomized controlled trials have examined the effects of adding insulin to patients already on a GLP-1 RA regimen and whose T2DM was considered uncontrolled [18,19,20]